Nicole G Griffin1, Yu Wang2, Christine M Hulette3, Matt Halvorsen1, Kenneth D Cronin4, Nicole M Walley5, Michael M Haglund6, Rodney A Radtke7, J H Pate Skene2, Saurabh R Sinha7, Erin L Heinzen1,8. 1. Institute for Genomic Medicine, Columbia University, New York, New York, U.S.A. 2. Department of Neurobiology, Duke University School of Medicine, Durham, North Carolina, U.S.A. 3. Department of Pathology, Duke University School of Medicine, Durham, North Carolina, U.S.A. 4. Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, U.S.A. 5. Division of Medical Genetics, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, U.S.A. 6. Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, U.S.A. 7. Department of Neurology, Duke University School of Medicine, Durham, North Carolina, U.S.A. 8. Department of Pathology and Cell Biology, Columbia University, New York, New York, U.S.A.
Abstract
OBJECTIVE: Hippocampal sclerosis is the most common neuropathologic finding in cases of medically intractable mesial temporal lobe epilepsy. In this study, we analyzed the gene expression profiles of dentate granule cells of patients with mesial temporal lobe epilepsy with and without hippocampal sclerosis to show that next-generation sequencing methods can produce interpretable genomic data from RNA collected from small homogenous cell populations, and to shed light on the transcriptional changes associated with hippocampal sclerosis. METHODS: RNA was extracted, and complementary DNA (cDNA) was prepared and amplified from dentate granule cells that had been harvested by laser capture microdissection from surgically resected hippocampi from patients with mesial temporal lobe epilepsy with and without hippocampal sclerosis. Sequencing libraries were sequenced, and the resulting sequencing reads were aligned to the reference genome. Differential expression analysis was used to ascertain expression differences between patients with and without hippocampal sclerosis. RESULTS: Greater than 90% of the RNA-Seq reads aligned to the reference. There was high concordance between transcriptional profiles obtained for duplicate samples. Principal component analysis revealed that the presence or absence of hippocampal sclerosis was the main determinant of the variance within the data. Among the genes up-regulated in the hippocampal sclerosis samples, there was significant enrichment for genes involved in oxidative phosphorylation. SIGNIFICANCE: By analyzing the gene expression profiles of dentate granule cells from surgically resected hippocampal specimens from patients with mesial temporal lobe epilepsy with and without hippocampal sclerosis, we have demonstrated the utility of next-generation sequencing methods for producing biologically relevant results from small populations of homogeneous cells, and have provided insight on the transcriptional changes associated with this pathology. Wiley Periodicals, Inc.
OBJECTIVE:Hippocampal sclerosis is the most common neuropathologic finding in cases of medically intractable mesial temporal lobe epilepsy. In this study, we analyzed the gene expression profiles of dentate granule cells of patients with mesial temporal lobe epilepsy with and without hippocampal sclerosis to show that next-generation sequencing methods can produce interpretable genomic data from RNA collected from small homogenous cell populations, and to shed light on the transcriptional changes associated with hippocampal sclerosis. METHODS: RNA was extracted, and complementary DNA (cDNA) was prepared and amplified from dentate granule cells that had been harvested by laser capture microdissection from surgically resected hippocampi from patients with mesial temporal lobe epilepsy with and without hippocampal sclerosis. Sequencing libraries were sequenced, and the resulting sequencing reads were aligned to the reference genome. Differential expression analysis was used to ascertain expression differences between patients with and without hippocampal sclerosis. RESULTS: Greater than 90% of the RNA-Seq reads aligned to the reference. There was high concordance between transcriptional profiles obtained for duplicate samples. Principal component analysis revealed that the presence or absence of hippocampal sclerosis was the main determinant of the variance within the data. Among the genes up-regulated in the hippocampal sclerosis samples, there was significant enrichment for genes involved in oxidative phosphorylation. SIGNIFICANCE: By analyzing the gene expression profiles of dentate granule cells from surgically resected hippocampal specimens from patients with mesial temporal lobe epilepsy with and without hippocampal sclerosis, we have demonstrated the utility of next-generation sequencing methods for producing biologically relevant results from small populations of homogeneous cells, and have provided insight on the transcriptional changes associated with this pathology. Wiley Periodicals, Inc.
Authors: Aleksandar J Ristić; Danijela Savić; Dragoslav Sokić; Jelena Bogdanović Pristov; Jelena Nestorov; Vladimir Baščarević; Savo Raičević; Slobodan Savić; Ivan Spasojević Journal: Epilepsia Date: 2015-04-09 Impact factor: 5.864
Authors: J Crèvecoeur; R M Kaminski; B Rogister; P Foerch; C Vandenplas; M Neveux; M Mazzuferi; J Kroonen; C Poulet; D Martin; B Sadzot; E Rikir; H Klitgaard; G Moonen; M Deprez Journal: Neuropathol Appl Neurobiol Date: 2014-02 Impact factor: 8.090
Authors: Cole Trapnell; Brian A Williams; Geo Pertea; Ali Mortazavi; Gordon Kwan; Marijke J van Baren; Steven L Salzberg; Barbara J Wold; Lior Pachter Journal: Nat Biotechnol Date: 2010-05-02 Impact factor: 54.908
Authors: Dominique F Leitner; James D Mills; Geoffrey Pires; Arline Faustin; Eleanor Drummond; Evgeny Kanshin; Shruti Nayak; Manor Askenazi; Chloe Verducci; Bei Jun Chen; Michael Janitz; Jasper J Anink; Johannes C Baayen; Sander Idema; Erwin A van Vliet; Sasha Devore; Daniel Friedman; Beate Diehl; Catherine Scott; Roland Thijs; Thomas Wisniewski; Beatrix Ueberheide; Maria Thom; Eleonora Aronica; Orrin Devinsky Journal: Neurology Date: 2021-04-28 Impact factor: 11.800
Authors: Anteneh M Feyissa; Anna Carrano; Xue Wang; Mariet Allen; Nilüfer Ertekin-Taner; Dennis W Dickson; Mark E Jentoft; Steven S Rosenfeld; William O Tatum; Anthony L Ritaccio; Hugo Guerrero-Cázares; Alfredo Quiñones-Hinojosa Journal: Epilepsy Res Date: 2021-03-18 Impact factor: 2.991
Authors: Prashant Kumar Srivastava; Marta Bagnati; Andree Delahaye-Duriez; Jeong-Hun Ko; Maxime Rotival; Sarah R Langley; Kirill Shkura; Manuela Mazzuferi; Bénédicte Danis; Jonathan van Eyll; Patrik Foerch; Jacques Behmoaras; Rafal M Kaminski; Enrico Petretto; Michael R Johnson Journal: Genome Res Date: 2017-03 Impact factor: 9.043
Authors: Toni C Berger; Magnus D Vigeland; Hanne S Hjorthaug; Lars Etholm; Cecilie G Nome; Erik Taubøll; Kjell Heuser; Kaja K Selmer Journal: PLoS One Date: 2019-12-30 Impact factor: 3.240